Villoutreix B O, Lilja H, Pettersson K, Lövgren T, Teleman O
Technical Research Centre of Finland, Espoo, Finland.
Protein Sci. 1996 May;5(5):836-51. doi: 10.1002/pro.5560050505.
Prostate-specific antigen (PSA), produced by prostate cells, provides an excellent serum marker for prostate cancer. It belongs to the human kallikrein family of enzymes, a second prostate-derived member of which is human glandular kallikrein-1 (hK2). Active PSA and hK2 are both 237-residue kallikrein-like proteases, based on sequence homology. An hK2 model structure based on the serine protease fold is presented and compared to PSA and six other serine proteases in order to analyze in depth the role of the surface-accessible loops surrounding the active site. The results show that PSA and hK2 share extensive structural similarity and that most amino acid replacements are centered on the loops surrounding the active site. Furthermore, the electrostatic potential surfaces are very similar for PSA and hK2. PSA interacts with at least two serine protease inhibitors (serpins): alpha-1-antichymotrypsin (ACT) and protein C inhibitor (PCI). Three-dimensional model structures of the uncleaved ACT molecule were developed based upon the recent X-ray structure of uncleaved antithrombin. The serpin was docked both to PSA and hK2. Amino acid replacements and electrostatic complementarities indicate that the overall orientation of the proteins in these complexes is reasonable. In order to investigate PSA's heparin interaction sites, electrostatic computations were carried out on PSA, hK2, protein C, ACT, and PCI. Two heparin binding sites are suggested on the PSA surface and could explain the enhanced complex formation between PSA and PCI, while inhibiting the formation of the ACT-PSA complex, PSA, hK2, and their preliminary complexes with ACT should facilitate the understanding and prediction of structural and functional properties for these important proteins also with respect to prostate diseases.
前列腺特异性抗原(PSA)由前列腺细胞产生,是前列腺癌的一种优良血清标志物。它属于人类激肽释放酶家族的酶,该家族的第二个源自前列腺的成员是人类腺激肽释放酶-1(hK2)。基于序列同源性,活性PSA和hK2都是由237个残基组成的类激肽释放酶蛋白酶。本文提出了一种基于丝氨酸蛋白酶折叠的hK2模型结构,并将其与PSA和其他六种丝氨酸蛋白酶进行比较,以便深入分析活性位点周围表面可及环的作用。结果表明,PSA和hK2具有广泛的结构相似性,且大多数氨基酸替换集中在活性位点周围的环上。此外,PSA和hK2的静电势表面非常相似。PSA与至少两种丝氨酸蛋白酶抑制剂(丝氨酸蛋白酶抑制剂)相互作用:α-1-抗糜蛋白酶(ACT)和蛋白C抑制剂(PCI)。基于未切割抗凝血酶的最新X射线结构,构建了未切割ACT分子的三维模型结构。该丝氨酸蛋白酶抑制剂与PSA和hK2都进行了对接。氨基酸替换和静电互补性表明这些复合物中蛋白质的整体取向是合理的。为了研究PSA的肝素相互作用位点,对PSA, hK2, 蛋白C, ACT和PCI进行了静电计算。在PSA表面提出了两个肝素结合位点,这可以解释PSA与PCI之间增强的复合物形成,同时抑制ACT-PSA复合物的形成。PSA、hK2及其与ACT的初步复合物应有助于理解和预测这些重要蛋白质在前列腺疾病方面的结构和功能特性。